APA (7th ed.) Citation

Duan, T., Xu, M., Zhang, H., Wu, S., Wang, H., & Guo, Z. Long-term follow-up of combination therapy with pembrolizumab and anlotinib in thoracic SMARCA4-deficient undifferentiated tumor: A case report and molecular features. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Duan, Ting, Mingxin Xu, Haibo Zhang, Shengchang Wu, Haochu Wang, and Zhenying Guo. Long-term Follow-up of Combination Therapy with Pembrolizumab and Anlotinib in Thoracic SMARCA4-deficient Undifferentiated Tumor: A Case Report and Molecular Features. Frontiers Media S.A.

MLA (9th ed.) Citation

Duan, Ting, et al. Long-term Follow-up of Combination Therapy with Pembrolizumab and Anlotinib in Thoracic SMARCA4-deficient Undifferentiated Tumor: A Case Report and Molecular Features. Frontiers Media S.A.